Article Text
Statistics from Altmetric.com
I thank Julie Hersh for her thoughtful and valuable comments on the use of electroconvulsive therapy (ECT).1 Discussions with those who have experience of treatments (such as ECT) is of the utmost importance when debating issues such as informed consent. I am therefore very pleased to be given this opportunity to respond. Hersh offers three main criticisms of my paper but I hope to show that the tenets of the paper are not undermined by her commentary.
Hersh's first criticism stems from her personal experience: she claims that, ‘The results of ECT for me were miraculous’. She argues that ECT ‘works’ and we have ‘70 years of remarkably positive experience’ to support this fact. In response, I agree that there are certainly patients who believe that ECT has been a highly effective intervention: but equally, there are others who have experienced intolerable side effects as a result.2 ECT is a controversial treatment precisely because of the serious long-term risk of memory loss.3 ,4 If we are to strive for the best healthcare possible, we cannot base our conclusions merely on positive cases: we need to consider all cases (and this is why providing information on side effects is extremely important for this form of treatment). Thus, I reject her conclusion that ECT is ‘remarkably positive’ for all patients: studies do not unequivocally support Hersh's fortunate experiences. In addition, I must also challenge the assumption that ECT ‘works’. Counterintuitive as …
Footnotes
-
Funding None.
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Electroconvulsive therapy, the placebo effect and informed consent
- Informed consent and ECT: how much information should be provided?
- Electroconvulsive therapy: a life course approach for recurrent depressive disorder
- Electroconvulsive therapy (ECT) from the patient's perspective
- Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far
- Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: protocol for a systematic review and network meta-analysis
- ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression
- ‘Delusional’ consent in somatic treatment: the emblematic case of electroconvulsive therapy
- Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis
- Electroconvulsive therapy, catatonia, deep vein thrombosis and anticoagulant treatment: a case report